Detail

Study ID: COG AALL1231

Title:

A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy)

Location:
Fargo Region
Principal Investigator:
Samuel Anim, MD
Disease:
ALL (Acute Lymphocytic Leukemia)
Stage:
Phase III
Status:
Active - Open to Accrual